David Engelhardt

David Engelhardt has been employed in equity research at TraderFox GmbH since April 2022. David completed his Bachelor's degree in Economics at Friedrich-Alexander-University in Erlangen-Nuremberg in 2018 and subsequently obtained a Master's degree in Business Administration at the University of Bamberg. Since 2019, he has been independently engaged with the topics of stock markets, equities, and capital markets. For the equity magazine, he is mainly responsible for the Hot News section and regularly publishes his own articles there. Since March 2023, he has been reporting as the editor-in-chief for the Traderfox equity magazine Small Caps Investor about small companies with enormous growth potential.

Latest from David Engelhardt

PBF Energy: The Crude Oil Refiner - How to Squeeze Clean Returns from Dirty Oil

PBF Energy focuses completely on the refining of crude oil and downstream logistics as an independent...

Delek US Holdings: Between Refining Margins, Midstream Stability, and Strategic Change

Delek US primarily generates its revenue in the refining business through the margin between crude...

Kymera Therapeutics: The Biotech Company Is Taking on Billion-Dollar Markets with Targeted Protein Destruction

Through targeted protein degradation, Kymera utilizes a biological recycling system that completely...

Marathon Petroleum: The Underestimated Cash Flow Machine of the US Stock Market

Marathon Petroleum is the largest independent refinery operator in the USA, primarily earning its...

CG Oncology: The Million-Dollar Bet on the Bladder Cancer Breakthrough

CG Oncology is a late-stage biopharma company focusing on the development of a bladder-preserving...

Eton Pharmaceuticals: Specialty Medications as a Growth Guarantee

Eton Pharmaceuticals bypasses the expensive failures of traditional drug research by optimizing and...

Travere Therapeutics: The Covert Monopoly in the Kidney Market

Travere Therapeutics owns the first and only approved therapy for the rare kidney disease FSGS with...

Virtu Financial: The Invisible High-Performance Engine of the Global Markets

Virtu Financial generates its revenues as a leading electronic market maker primarily through the...

Amylyx Pharmaceuticals: The Stock is Seeing a Significant Increase Due to the GLP-1 Success

After the setback with the former hope Relyvrio, Amylyx Pharmaceuticals has successfully realigned...

Moderna: From Pandemic Beneficiary to Cancer Pioneer

Moderna operates a programmable mRNA platform that enables rapid development of medical blueprints...

Aveanna Healthcare: The Care Market in Transition - How Aveanna Capitalizes on the Megatrend

Aveanna Healthcare has overcome operational hurdles, improved its contracts with payers, and is back...

Arrowhead Pharmaceuticals: Targeting the Genome Rocket: How to Reprogram Medicine

Arrowhead Pharmaceuticals develops highly precise RNAi therapeutics that directly target and silence...

Red Violet: The Margin-Rich AI Powerhouse in the Battle for Data and Identities

Red Violet connects billions of datasets on cloud-based, AI-driven platforms for identity verification...

Twist Bioscience: The DNA Factory Approaching an Operational Turning Point

Twist Bioscience has revolutionized DNA manufacturing by printing genetic building blocks on proprietary...

Climb Bio: Promising Pipeline Meets Well-Filled Coffers

Climb Bio is a clinical-stage biotech company specializing in the development of novel antibody therapies...

Climb Bio: Promising Pipeline Meets Well-Filled Coffers

Climb Bio is a clinical-stage biotech company that specializes in developing novel antibody therapies...

Praxis Precision Medicines: Between FDA Approval and Billion-Dollar Market

Praxis Precision Medicines is a US biopharmaceutical company that researches therapies for severe...

Cheesecake Factory: Here's how the Company is Shaking Up the US Restaurant Market

The Cheesecake Factory is an established US restaurant group with nearly $4 billion in annual revenues,...

BrightSpring Health Services: The Silent Giant in the US Care Market

BrightSpring combines specialized pharmaceutical care with qualified home healthcare and generates...

Chefs' Warehouse: Exclusivity on a Plate: How to Conquer Fine Dining

Chefs' Warehouse exclusively supplies the upscale gastronomy sector with specialties and secures noticeably...